Panhematin Powder, For Solution
Product Images NDC 55292-702

4 FDA label images from Recordati Rare Diseases, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Panhematin (NDC 55292-702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Recordati Rare Diseases, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Of Hemin (Image 01)

Structural Formula Of Hemin (Image 01)
Chemical structure of hemin, the active ingredient in Panhematin 7 mg/mL powder for solution intravenous drug.*
FDA Label Image

Clinical Response After Hemin Therapy (Image 02)

Clinical Response After Hemin Therapy (Image 02)
A bar chart titled Clinical Response after Hemin Therapy showing percentage of treatment courses with Clinical Response at 85.5% (Yes) and 14.5% (No), and Chemical Response at 100% (Yes) and 0% (No). The x-axis lists Clinical Response and Chemical Response categories, and the y-axis represents Percentage of Treatment Courses up to 120%.*
FDA Label Image

Logo (Panhematin 01)

FDA Label Image

Principal Display Panel (350 mg Vial Carton)

Principal Display Panel (350 mg Vial Carton)
Packaging label for Panhematin 350 mg sterile powder for injection, hemin for intravenous infusion. The label shows the product contains one vial, with 350 mg hemin per vial. It includes mixing directions, storage instructions (20-25°C), and inactive ingredients. Labeler is Recordati Rare Diseases, Inc. The label also displays the NDC 55292-702-55 and branding with Recordati Rare Diseases logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.